Celltrion, Inc. Stock OTC Markets
Stocks
CONIF
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 45,336B 32.89B 28.34B 26.58B 24.26B 45.7B 3,144B 45.85B 315B 123B 1,587B 124B 121B 5,262B | P/E 2026 * |
29x | P/E 2027 * | 25.1x |
|---|---|---|---|---|---|
| Enterprise Value | 47.53B 34.49M 29.72M 27.87M 25.44M 47.92M 3.3B 48.07M 331M 129M 1.66B 129M 127M 5.52B | EV / Sales 2026 * |
8.67x | EV / Sales 2027 * | 7.43x |
| Free-Float |
60.59% | Yield 2026 * |
0.4% | Yield 2027 * | 0.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 20/03/2015 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 26/03/2021 |
Hyeok-Jae Lee
PSD | President | 50 | 13/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 01/04/2005 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 33.21B | |
| -1.10% | -1.53% | +1.37% | +18.39% | 50.47B | |
| -3.12% | -0.75% | +447.48% | +524.26% | 44.56B | |
| -1.79% | +0.74% | +37.18% | +16.57% | 43.08B | |
| -3.82% | -2.07% | +19.83% | +73.63% | 41.7B | |
| -0.31% | -0.83% | +19.47% | +48.24% | 33.21B | |
| -2.08% | -3.24% | +26.32% | +121.63% | 16.77B | |
| +0.39% | -2.12% | - | - | 16.28B | |
| -0.15% | -1.38% | +11.19% | +27.11% | 14.58B | |
| -0.72% | -1.25% | +78.49% | +39.02% | 13.92B | |
| Average | -1.29% | -1.39% | +80.17% | +108.61% | 30.51B | |
| Weighted average by Cap. | -1.57% | -1.21% | +95.94% | +126.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,480B 3.98B 3.43B 3.21B 2.93B 5.52B 380B 5.54B 38.12B 14.87B 192B 14.93B 14.6B 636B | 6,294B 4.57B 3.94B 3.69B 3.37B 6.34B 436B 6.36B 43.77B 17.08B 220B 17.15B 16.77B 731B |
| Net income | 1,511B 1.1B 945M 886M 808M 1.52B 105B 1.53B 10.51B 4.1B 52.89B 4.12B 4.03B 175B | 1,763B 1.28B 1.1B 1.03B 944M 1.78B 122B 1.78B 12.26B 4.79B 61.73B 4.8B 4.7B 205B |
| Net Debt | 2,199B 1.6B 1.37B 1.29B 1.18B 2.22B 152B 2.22B 15.29B 5.97B 76.96B 5.99B 5.86B 255B | 1,409B 1.02B 881M 826M 754M 1.42B 97.71B 1.42B 9.8B 3.82B 49.32B 3.84B 3.75B 164B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
